Contributors
Dr. John O'Brien
Life/Health Chief Medical Officer, London
John O’Brien is a specialist physician and pulmonologist. In 2016 he joined Gen Re full-time as the Chief Medical Officer (CMO) for the Global Underwriting and Research & Development department. He is now the CMO for the CUSAC segment covering Canada, UK, Ireland, Southern Africa, Australia and New Zealand, and continues to support the R&D department.
-
Why Are We Still Waiting for a Vaccine for HIV?
Issue: Dec 01, 2021English
In view of the rapid development of a number of vaccines against the SARS-CoV-2 virus, the question has been asked, why we are still awaiting an HIV vaccine?
Read More -
COVID-19 - We Got the Shot. Now What?
By Dr. John O'Brien May 06, 2021English
Over the last year, the pandemic caused by the SARS‑CoV‑2 virus has devastated economies and resulted in tremendous individual suffering and loss of life. Fortunately, in the recent past effective vaccines and vaccination programs have resulted in control...
Read More -
Underwriting Focus 2020, No. 2
Issue: Feb 22, 2021English
This edition of Underwriting Focus covers different topics around the COVID-19 pandemic – Changes in scientific findings, vaccine development, mental health implications and underwriting recommendations for new diseases.
Login Required - Client Only Read More -
Liquid Biopsy and the Early Diagnosis of Cancer
Issue: Nov 02, 2020English
In recent years, the primary tool for early diagnosis of cancer has been liquid biopsy (a blood test), but it remains complex, costly and time-consuming to fully screen for all mutations.
Read More
Most Popular
Topics
Capital Management
Life/Health
Property/Casualty
Contributors
Get to know our global experts
